The inhibition of the pro-inflammatory NF-κB pathway, diminishment of free radical creation and an anti-apoptotic property may prove to be helpful in slowing down atherosclerosis and cardiac fibrosis developments. This evidence concerns the gene NFKB1 and atherosclerosis.